What You Should Know:
This week, AmerisourceBergen announced plans to launch DTx Connect, a fully integrated ordering, dispensing and fulfillment platform that aims to facilitate patient access to physician-ordered digital therapeutics and diagnostics.
- Several developers plan to pilot DTx Connect, which aims to reduce barriers that physicians and patients face across the ordering and fulfillment of digital therapeutics and diagnostics.
Digital Therapeutics Market
Read More
prescription digital therapeutic
Anthem Partners With Happify Health to Enhance Maternal Health
What You Should Know:
- Anthem, Inc. today announced a collaboration between Happify Health to bridge the gap between the unique physical and mental health concerns women face.
- The collaboration will add to its ongoing support of the whole health of women with the addition of a new a digital-first solution in select markets.
Enhance Maternal Health with New Digital-First Solution
It is part of Anthem’s early and consistent support of women throughout the entirety of their maternal
Read More
Pear Therapeutics Acquires 2 Depression Assets to Optimize Depression Product Candidate
What You Should Know:
- Pear Therapeutics, Inc. (Nasdaq: PEAR), announced it has acquired two new digital therapeutic assets that it intends to integrate into a potential prescription digital therapeutic (PDT) to treat patients across a continuum of depression subtypes and severities.
- Additionally, Pear announced yesterday the expansion of its existing initiative with Crossroads. Through this expansion, Pear’s PDTs, reSET® and reSET-O®, have the potential to reach thousands of additional
Read More
Pear Therapeutics Goes Public Via $1.6B SPAC Deal – Digital Health IPO
What You Should Know:
- Pear Therapeutics, the leader in developing and commercializing prescription digital therapeutics to treat serious disease, and Thimble Point Acquisition Corp (Nasdaq: THMA), a special purpose acquisition company (SPAC) whose management team is associated with the Pritzker Vlock Family Office, today announced that they have entered into a definitive business combination agreement.
- Pursuant to the Business Combination Agreement, upon closing of the
Read More
Highmark BCBS Expands Access to Freespira’s Digital Therapeutic to Help Treat PTSD, Panic Attacks
What You Should Know:
- Health insurer Highmark expands access to FDA-cleared digital therapeutic Freespira proven to reduce the symptoms of panic disorder and PTSD for members in Pennsylvania, Delaware and Virginia.
- The announcement follows a pilot study finding that nearly 9 out of 10 patients using the solution were symptom-free after treatment.
Highmark Inc., the fourth-largest Blue Cross Blue Shield-affiliated organization announced it is expanding access to Freespira’s
Read More
Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms
What You Should Know:
- Lightspeed Venture Partners, the VC behind Nest and GrubHub, is leading a $10 million round for Freespira, an FDA-cleared digital therapeutic proven to significantly reduce or eliminate panic attacks and PTSD symptoms by training users to normalize respiratory irregularities.
- In 28 days, Freespira can reduce or eliminate panic
attacks and PTSD symptoms from home with just a tablet, sensor, and custom app.
There’s no medicine with possible side effects and no need
Read More
Pear Therapeutics Raises $80M to Advance Prescription Digital Therapeutics
What You Should Know:
- Pear Therapeutics today announced that it has
successfully closed an $80 million Series D financing led by SoftBank Vision
Fund 2.
- Pear is the
leader in prescription digital therapeutics and the first company to receive
FDA authorization for a prescription digital therapeutic (PDT) to treat
disease.
- Pear currently has three FDA authorized therapies, reSET, reSET-O and Somryst, for substance use disorder, opioid use disorder, and chronic insomnia,
Read More
PreferredOne Becomes First Health Plan to Cover Prescription Digital Therapeutics
What You Should Know:
- PreferredOne teams with Pear to provide its members
with covered access to two prescription digital therapeutics (PDTs) for the
treatment of substance use disorder (SUD) and opioid use disorder (OUD)
- PDTs are a new therapeutic class that uses software to
directly treat disease. Like traditional medicines, PDTs are tested in
randomized controlled trials demonstrating safety and effectiveness, evaluated
and authorized by regulators like FDA, and used under the
Read More
Through EHR Integration, CVS Specialty Launches Specialty Expedite to Streamline Prescription Onboarding
- CVS Specialty launches Specialty Expedite, a pharmacy solution that uses technology to significantly streamline the process and keep patients informed of the status of their prescription along the way.
- Streamlined prior authorization and benefits verification process using connectivity with EHR platforms, helping patients get their medications in as little as three days.
- Patients are also able to choose how they want to get their specialty medications – at their local CVS
Read More
XRHealth, Allscripts Partner to Integrate VR/AR Platforms, Leveraging Open APIs
- XRHealth forms a partnership with Allscripts to provide integrated VR/AR platform, leveraging Allscripts Open APIs.
- The partnership enables medical professionals to prescribe and monitor the progress of VR/AR therapies on patient health.
XRHealth, formerly known as VRHealth, a provider of in extended reality and therapeutic applications, today announced a partnership with Allscripts to provide an integrated VR/AR platform, leveraging Allscripts Open APIs. The Allscripts Developer Program
Read More
